Physician profile
Hamid Shah
NPI 1679693931
$6,730.62
in general payments reported to CMS, 2019-2025
16 companies · $2,796 in 2025
The $2,796 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $423 · 2021: $287 · 2022: $574 · 2023: $738 · 2024: $1,114 · 2025: $2,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,184 · Travel and Lodging: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,184.07 |
| Travel and Lodging | $1,464.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,286.62 | 2024-2025 | |
| Medtronic USA, INC. | $954.40 | 2019-2020 | |
| Abbott Laboratories | $935.64 | 2019-2025 | Eterna, Proclaim, Penta |
| Medtronic, INC. | $826.34 | 2021-2025 | Intellis Adaptivestim, Mazor X System, Midas Rex |
| Arthrex, INC. | $557.22 | 2025 | |
| Baxter Healthcare | $532.25 | 2024-2025 | Floseal |
| Boston Scientific Corporation | $347.34 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Si-Bone, INC. | $286.29 | 2024-2025 | |
| Zimvie INC. | $225.20 | 2023 | |
| Integra Lifesciences Corporation | $224.83 | 2022-2023 | Codman Certas, Codman Hakim, Cusa Clarity |
| Globus Medical, INC. | $179.08 | 2023-2024 | Excelsius Deformity, Quartex |
| Stryker Corporation | $131.90 | 2022-2025 | Adherus Autospray Dural Sealant |
| Orthofix Medical, INC. | $126.87 | 2020-2021 | |
| Ethicon US, LLC | $71.92 | 2025 | Vistaseal |
| Depuy Synthes Sales INC. | $26.81 | 2023 | Viper |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $17.91 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.